FAM104B activators are a diverse group of compounds that exert their effects through various biochemical pathways, leading to the enhanced activity of this protein. For instance, certain activators work by increasing intracellular cAMP levels, either through direct stimulation of adenylate cyclase or by inhibiting the degradation of cAMP by phosphodiesterases, thereby creating a conducive environment for the activation of FAM104B within cAMP-dependent pathways. Other activators might achieve a similar effect by acting as beta-adrenergic agonists, which stimulate the same adenylate cyclase, or by serving as cell-permeable analogs of cAMP that directly elevate the intracellular concentration of this crucial second messenger. Furthermore, FAM104B activity can also be influenced by compounds that modulate protein kinase C or activate the JNK/SAPK signaling pathways, suggesting a role for this protein in cellular stress response mechanisms.
Additionally, the modulation of intracellular calcium levels through the use of calcium ionophores can have an indirect impact on FAM104B, by triggering a cascade of calcium-dependent signaling events. Furthermore, the inhibition of serine/threonine protein phosphatases by specific inhibitors can lead to increased phosphorylation within the cell, which may also indirectly increase FAM104B activity. In parallel, compounds that affect ion gradients, such as those that inhibit the Na+/K+-ATPase pump, can alter secondary messenger pathways and thus potentially affect FAM104B activity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-specific inhibitor of phosphodiesterases, which prevents cAMP degradation, thus potentially increasing FAM104B activity through elevated cAMP pools. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activator of protein kinase C (PKC) which may upregulate FAM104B activity as part of downstream signaling cascades involving PKC. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Beta-adrenergic agonist that stimulates adenylate cyclase, leading to increased cAMP and possible upregulation of FAM104B via cAMP-dependent pathways. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Activator of the JNK/SAPK signaling pathway, which could upregulate FAM104B activity by modulating cellular stress response pathways. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Calcium ionophore that raises intracellular calcium levels, potentially influencing FAM104B activity through calcium-dependent signaling mechanisms. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcium ionophore which may indirectly activate FAM104B through alterations in calcium signaling. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels in the cell and possible indirect activation of FAM104B. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Specific inhibitor of serine/threonine protein phosphatases, which can result in augmented phosphorylation signaling potentially affecting FAM104B activity. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Cell-permeable cAMP analog that can directly increase intracellular cAMP levels, thus potentially enhancing FAM104B activity through cAMP-dependent protein kinase pathways. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
Inhibitor of the Na+/K+-ATPase pump, which can lead to alterations in ion gradients and secondary messenger pathways, possibly influencing FAM104B activity. | ||||||